# Impact of Guidelines on Cardiovascular and Economic Outcomes With Focus on Lipid Lowering Drugs

> **NCT02929550** · — · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 5304 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **OTHER:** Well-controlled

## Key facts

- **NCT ID:** NCT02929550
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-04
- **Target enrollment:** 5304 (ACTUAL)
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929550, "Impact of Guidelines on Cardiovascular and Economic Outcomes With Focus on Lipid Lowering Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02929550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*